Loading
Latest filing published 12 Sept 2018 for RISE Life Science Corp..
No signal scores available.
Michael Campbell discloses dealings in RISE Life Science Corp. to SEDI. The record holds 2 filings, for trades running from 27 February 2018 to 12 September 2018.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 12 September 2018 came the latest disclosure, a transaction in RISE Life Science Corp. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations